| 2017-05-19 05:05:10 | athenahealth upgraded to Hold from Underperform at JefferiesJefferies analyst Sean Dodge upgraded athenahealth to Hold saying the involvement of activist Elliott Associates limits near-term downside and increases the chances of a sale. The analyst remains concerned about the company's fundamentals, however. A sale is a low probability event but can't be ruled out, Dodge tells investors in a research note. He upped his price target for athenahealth to $135 from $95. | |
|---|---|---|
| ||
| ||
| ||
| ||
| | |
| , … |
| |
| ||
| | |
| | |
| | |
| |
| ||
| | |
| , |
| |
| , |
| |
|
| | |
| , … |
| |
| , |
| |
| | |
| , … |
| |
| | |
| | |
| ||
| | |
| |